249 related articles for article (PubMed ID: 18572420)
1. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.
Soliman OI; van Dalen BM; Theuns DA; ten Cate FJ; Nemes A; Jordaens LJ; Geleijnse ML
J Diabetes Complications; 2009; 23(5):365-70. PubMed ID: 18572420
[TBL] [Abstract][Full Text] [Related]
2. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
[TBL] [Abstract][Full Text] [Related]
3. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
[TBL] [Abstract][Full Text] [Related]
4. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.
Bertini M; Delgado V; den Uijl DW; Nucifora G; Ng AC; van Bommel RJ; Borleffs CJ; Boriani G; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2010 Jan; 3(1):86-93. PubMed ID: 19920028
[TBL] [Abstract][Full Text] [Related]
5. Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy.
Shanks M; Delgado V; Ng AC; Auger D; Mooyaart EA; Bertini M; Marsan NA; van Bommel RJ; Holman ER; Poldermans D; Schalij MJ; Bax JJ
Am Heart J; 2011 Mar; 161(3):552-7. PubMed ID: 21392611
[TBL] [Abstract][Full Text] [Related]
6. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
[TBL] [Abstract][Full Text] [Related]
7. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
[TBL] [Abstract][Full Text] [Related]
9. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
[TBL] [Abstract][Full Text] [Related]
10. Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy.
Sassone B; Capecchi A; Boggian G; Gabrieli L; Saccà S; Vandelli R; Petracci E; Mele D
Am J Cardiol; 2007 Aug; 100(3):470-5. PubMed ID: 17659931
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
Auger D; van Bommel RJ; Bertini M; Delgado V; Ng AC; Ewe SH; Shanks M; Marsan NA; Mooyaart EA; Witkowski T; Poldermans D; Schalij MJ; Bax JJ
Am Heart J; 2010 Oct; 160(4):737-43. PubMed ID: 20934569
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
[TBL] [Abstract][Full Text] [Related]
14. Reverse of left ventricular volumetric and structural remodeling in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Geleijnse ML; Theuns DA; Nemes A; Vletter WB; van Dalen BM; Motawea AK; Jordaens LJ; ten Cate FJ
Am J Cardiol; 2008 Mar; 101(5):651-7. PubMed ID: 18308015
[TBL] [Abstract][Full Text] [Related]
15. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy.
Aksoy H; Okutucu S; Kaya EB; Deveci OS; Evranos B; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
Europace; 2010 Sep; 12(9):1256-61. PubMed ID: 20478931
[TBL] [Abstract][Full Text] [Related]
16. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
Feneon D; Behaghel A; Bernard A; Fournet M; Mabo P; Daubert JC; Leclercq C; Donal E
Heart Rhythm; 2015 Aug; 12(8):1800-6. PubMed ID: 25896013
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy.
Yu CM; Gorcsan J; Bleeker GB; Zhang Q; Schalij MJ; Suffoletto MS; Fung JW; Schwartzman D; Chan YS; Tanabe M; Bax JJ
Am J Cardiol; 2007 Oct; 100(8):1263-70. PubMed ID: 17920368
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
Yu CM; Fung JW; Chan CK; Chan YS; Zhang Q; Lin H; Yip GW; Kum LC; Kong SL; Zhang Y; Sanderson JE
J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1058-65. PubMed ID: 15363081
[TBL] [Abstract][Full Text] [Related]
19. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
20. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
